Stay updated on Nivolumab in EBV+ Lymphoproliferative Disorders Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in EBV+ Lymphoproliferative Disorders Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in EBV+ Lymphoproliferative Disorders Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    Change Detected
    Summary
    The study has been updated to version v2.10.0, with the previous version v2.9.7 now removed.
    Difference
    0.3%
    Check dated 2024-07-23T14:21:03.000Z thumbnail image
  5. Check
    5 days ago
    No Change Detected
  6. Check
    11 days ago
    Change Detected
    Summary
    The website has been updated to Revision v2.9.7 from v2.9.6.
    Difference
    0.1%
    Check dated 2024-07-16T06:18:14.000Z thumbnail image
  7. Check
    17 days ago
    Change Detected
    Summary
    The website now displays the actual last update posted instead of an estimated time, providing users with more accurate information.
    Difference
    0.0%
    Check dated 2024-07-09T23:47:23.000Z thumbnail image
  8. Check
    18 days ago
    Change Detected
    Summary
    The website has been updated with new information as of July 8, including an estimated last update date, while older information from June has been removed.
    Difference
    0.5%
    Check dated 2024-07-08T22:38:33.000Z thumbnail image
  9. Check
    25 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent change in the webpage content.
    Difference
    0.1%
    Check dated 2024-07-02T12:33:05.000Z thumbnail image
  10. Check
    30 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.3 to v2.9.5, indicating a recent change in the webpage content.
    Difference
    0.1%
    Check dated 2024-06-27T09:24:09.000Z thumbnail image

Stay in the know with updates to Nivolumab in EBV+ Lymphoproliferative Disorders Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in EBV+ Lymphoproliferative Disorders Clinical Trial page.